Seattle Genetics gets approval of TUKYSA in Switzerland for metastatic HER2-positive breast cancer Read more
Moderna Receives FDA Fast Track Designation for mRNA Vaccine (mRNA-1273) Against Novel Coronavirus Read more
Sarclisa (isatuximab) Phase 3 IKEMA trial meets primary endpoint early in patients with relapsed multiple myeloma Read more
Ocular Therapeutix Announces First Patient Dosed in Phase 1 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease Read more
Bellerophon Therapeutics Announces FDA Clears Initiation of Phase 3 Study for INOpulse Inhaled Nitric Oxide Therapy to Treat COVID-19 Read more
Themis collaborates with ABL Europe to manufacture its SARS-CoV-2 Vaccine Candidate in France Read more
CRISPR and Vertex announce FDA RMAT designation granted to CTX001 to treat severe hemoglobinopathies Read more
Enhertu granted Breakthrough Therapy Designation in the US for HER2-positive metastatic gastric cancer Read more
Dyno Therapeutics Emerges from Stealth to Transform Gene Therapy Using Artificial Intelligence Read more